Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Inflammatory Bowel Diseases|June 12, 2024
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn's Disease: A Prospective Pilot StudyLorenzo Bertani, Luca Antonioli, Marco Fornili, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 8, 2022
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumabLorenzo Bertani, Brigida Barberio, Marco Fornili, et al.
Inflammatory Bowel Diseases|April 2, 2020
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte RatioLorenzo Bertani, Federico Rossari, Brigida Barberio, et al.
Journal of Clinical Medicine|October 14, 2023
Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn's DiseaseLorenzo Bertani, Claudia D'Alessandro, Marco Fornili, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 5, 2015
Diagnosis and treatment of faecal incontinence: Consensus statement of the Italian Society of Colorectal Surgery and the Italian Association of Hospital Gastroenterologists, Filippo Pucciani, Donato Francesco Altomare, et al.
European Journal of Neurology|October 20, 2022
Intestinal histomorphological and molecular alterations in patients with Parkinson's diseaseGabriele Bellini, Laura Benvenuti, Chiara Ippolito, et al.
The American Journal of Gastroenterology|September 21, 2016
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERDNicola de Bortoli, Leonardo Frazzoni, Edoardo V Savarino, et al.
United European Gastroenterology Journal|June 9, 2018
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trialCesare Cremon, Simone Guglielmetti, Giorgio Gargari, et al.
Alimentary Pharmacology & Therapeutics|January 7, 2026
Blood Eosinophils Are Accurate Biomarkers for the Management of Eosinophilic Oesophagitis: Prospective, Multi-Centre StudyPierfrancesco Visaggi, Gaia Pellegatta, Stefano Siboni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 14, 2022
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP)Giovanni Barbara, Cesare Cremon, Massimo Bellini, et al.
Pageof 15